Takeda Pharmaceutical (TAK) Assets Average (2018 - 2026)

Takeda Pharmaceutical's Assets Average history runs 9 years deep, the most recent figure standing at $99.3 billion for Q1 2026.

• In Q1 2026, Assets Average rose 3.06% year-over-year to $99.3 billion; the TTM figure through Mar 2026 stood at $99.3 billion (up 3.06% YoY), while the FY2026 annual figure was $98.1 billion, down 1.06% from the prior year.
• Assets Average was $99.3 billion for Q1 2026 at Takeda Pharmaceutical, roughly flat from $99.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $112.6 billion in Q1 2022 to a low of $95.1 billion in Q2 2025.
• Historically, Assets Average has averaged $101.9 billion across 5 years, with a median of $100.6 billion in 2023.
• The sharpest annual moves came in 2022 and 2026: Assets Average fell 10.89% in 2022, then rose 3.06% in 2026.
• A 5-year view of Assets Average shows it stood at $100.6 billion in 2022, then declined by 1.0% to $99.6 billion in 2023, then slipped by 1.07% to $98.5 billion in 2024, then grew by 0.64% to $99.2 billion in 2025, then advanced by 0.17% to $99.3 billion in 2026.
• The last three Assets Average figures came in at $99.3 billion (Q1 2026), $99.2 billion (Q4 2025), and $97.5 billion (Q3 2025), per Business Quant data.